pharmaphorum9y
Takeda settles Actos damages case for $2.7bn
Takeda has agreed to pay an eye-watering $2.7 billion to settle claims that its diabetes drug Actos caused bladder cancer, in one of the largest cases of its kind in the pharma industry.
pharmaphorum4y
FDA approves first generic Actos to treat diabetes
The first generic version of Takeda Pharmaceutical’s diabetes drug, Actos (pioglitazone hydrochloride), has been approved by the FDA. US-based Mylan Pharmaceuticals gained FDA approval for 15 ...
Healthline3mon
Medications & Treatment
You may need to avoid some type 2 diabetes medications if you have certain conditions. For example, thiazolidinediones (Actos) aren’t recommended for people with liver problems or a history of ...
Healthline7mon
Metformin & Oral Meds
Pioglitazone (Actos) is an example of a thiazolidinedione ... The liver both stores and produces glucose. Some type 2 diabetes medications limit the liver’s ability to release glucose ...
Medscape3d
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia
By targeting insulin resistance, the members of the thiazolidinedione class of oral antihyperglycemic medications ... of type 2 diabetes: pioglitazone hydrochloride (Actos; Takeda Pharmaceuticals ...
New York Post26d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...